Mitolyn and MitoThrive have emerged as leading contenders in the health and wellness market, each promising innovative ...

Impact and progress Frontiers' impact Progress Report 2022 All progress reports ...

Nicotinamide adenine dinucleotide (NAD+) is an essential coenzyme ubiquitously present in all living cells, playing a pivotal ...

The first patient with relapsed/refractory acute myeloid leukemia has received KJ-C2320, an allogeneic CAR T-cell therapy targeting CD38 and developed using the THANK-uCAR platform, in an investigator ...

CARsgen Therapeutics Holdings Limited, a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumours, announces that KJ-C2320, an allogeneic CAR ...

Pre-Market: 9:28:52 a.m. EST ...